Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,822 0% |
 |
Gilead SciencesGILD |
77,639 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,665 0% |
 |
Inovio PharmaceuticalsINO |
92,124 0% |
 |
Anavex Life SciencesAVXL |
24,069 0% |
Tempest Therapeutics Stocktwits Subscriber Count
Tempest Therapeutics (TPST) has 12,650 subscribers on Stocktwits, down 1.7% over the past three months. A shrinking subscriber base can signal cooling retail investor attention.
With 12,650 subscribers, Tempest Therapeutics has a smaller Stocktwits following than Amgen (14,822) and Gilead Sciences (77,639).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How TPST’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking TPST. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Tempest Therapeutics’s Stocktwits community into the TPST AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see TPST Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Jun 2026 | 12,715 | |
| May 2026 | 12,806 | |
| Apr 2026 | 12,873 | |
| Mar 2026 | 12,907 | |
| Feb 2026 | 12,939 | |
| Jan 2026 | 13,005 |
Tempest Therapeutics Stocktwits Subscribers: Frequently Asked Questions
Tempest Therapeutics (TPST) has 12,650 subscribers (13K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Tempest Therapeutics's Stocktwits subscriber base is declining, down 1.7% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines TPST’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Tempest Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 8th percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Tempest Therapeutics.
See Tempest Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for TPST — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
